Tuesday, October 20, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $341.37 -0.46%
MSFT $529.29 -0.79%
GOOGL $343.35 -0.24%
AMZN $262.73 +0.10%
TSLA $369.68 +0.44%
META $683.25 -3.15%
NVDA $214.43 -1.23%
JPM $338.33 +1.44%
BTC $36.22 +0.22%
ETH $22.97 +0.70%
Latest Signing ceremony for contribution agreements between WHO and France Oct 17, 2024
AAPL
$341.37
▼ 0.46%
MSFT
$529.29
▼ 0.79%
GOOGL
$343.35
▼ 0.24%
AMZN
$262.73
▲ 0.10%
TSLA
$369.68
▲ 0.44%
META
$683.25
▼ 3.15%
NVDA
$214.43
▼ 1.23%
JPM
$338.33
▲ 1.44%

Top Stories

Markets →
All Markets Technology Economy Science Health Sports Entertainment Politics
Science Daily
Semaglutide (Ozempic) linked to fewer bone fractures despite greater weight loss
A large real-world study suggests semaglutide (Ozempic, Wegovy, Rybelsus) may offer an unexpected bonus for people with type 2 diabetes: stronger protection against bone fractures while delivering greater weight loss. Researchers analyzing health records from nearly 60,000 adults found that people taking semaglutide experienced about 15% fewer fractures than those using other common weight-loss medications, despite losing more weight.
science  Jun 16, 2026
Variety
Content Partners Secures Fresh Round of Funding From Carlyle Global Credit
Content Partners has struck a new deal with Carlyle Global Credit to facilitate fresh investment capital for the company that has been a pioneer in buying out ownership stakes and profit participation rights in movies and TV shows from individuals and production companies. Investment giant Carlyle owns the majority of Los Angeles-based Content Partners, which […]
entertainment  Jun 16, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free